Clinical Trials Logo

Panic Disorder clinical trials

View clinical trials related to Panic Disorder.

Filter by:

NCT ID: NCT04569760 Withdrawn - Clinical trials for Generalized Anxiety Disorder

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Start date: April 2021
Phase: Phase 3
Study type: Interventional

This proposed study aims to evaluate the efficacy of a daily oral cannabinoid oil preparation in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the relationship between inflammation, anxiety and cannabinoids using biological markers as well as examine the neuro-cognitive effects of cannabinoid treatment.

NCT ID: NCT04568109 Completed - Clinical trials for Panic Disorder With Agoraphobia

Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder

Start date: February 1, 2010
Phase: N/A
Study type: Interventional

The present study aims to investigate a potential mechanism of successful CBT for panic disorder, i.e., the reduction of excessive anxious apprehension and fear responses to panic-related body symptoms in the context of CBT treatment. In the present non-randomized interventional study, effects of cognitive behavior therapy on reported symptoms and fear responses to panic-related body symptoms are investigated. It is expected that symptom improvement during CBT is associated with a decrease in the activation of the brain's fear network to panic-related body symptoms.

NCT ID: NCT04433832 Recruiting - Clinical trials for Coronary Artery Disease

Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease

Start date: January 20, 2020
Phase:
Study type: Observational

The primary aim of this study is to establish how frequently patients with coronary artery disease present or develop two anxiety disorders (panic disorder and generalized anxiety disorder) in the two years following a medical intervention for their heart. A second objective is to assess the impact of these anxiety disorders on the health of these patients.

NCT ID: NCT04432155 Not yet recruiting - Panic Disorder Clinical Trials

Xenon Inhalation for Treatment of Panic Disorder

Start date: June 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with panic disorder.

NCT ID: NCT04366011 Completed - Panic Disorder Clinical Trials

Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder

Start date: November 2011
Phase: N/A
Study type: Interventional

The aim of the present study is to a) determine the comparative efficacy of the brief capnometry-assisted respiratory therapy (CART) and standard cognitive behavioural therapy (CBT), and b) to determine moderators and mediators. With the data collected from the study, the investigators will test the following hypotheses: (a) CART will be as effective in treating PD/A as CBT, albeit in shorter time, b) patients with greater respiratory dysregulations, especially hyperventilation, at pretreatment will benefit more from CART, whereas patients with greater cognitive dysregulation will benefit more from CBT. CART, but not CBT, will result in reversal of hyperventilation.

NCT ID: NCT04293341 Recruiting - Clinical trials for Major Depressive Disorder

Comparing Individual Therapies for Veterans With Depression, PTSD, and Panic Disorder

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Cognitive behavioral therapy (CBT) is a brief, efficient, and effective treatment for individuals with depressive/anxiety disorders. However, CBT is largely underutilized within the Department of Veterans Affairs due to the cost and burden of trainings necessary to deliver all of the related disorder-specific treatments (DSTs). Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol in Veterans with depressive/anxiety disorders, including posttraumatic stress disorder. The proposed research seeks to evaluate the efficacy of TBT by assessing psychiatric symptomatology and related impairment outcomes in Veterans with depressive/anxiety disorders via a randomized controlled trial of TBT and existing DSTs in Veterans with major depressive disorder, posttraumatic stress disorder, and panic disorder. Assessments will be completed at pre-, mid-, and post-treatment, and at 6-month follow-up. Process variables also will be investigated.

NCT ID: NCT04185896 Recruiting - Depression Clinical Trials

Perinatal Mental Health Care in Switzerland

MADRE
Start date: July 10, 2019
Phase:
Study type: Observational

This qualitative study with quantitative elements examines the health care provided to women who suffered from mental disorder during pregnancy and / or in the first year after birth (i.e. during the perinatal phase). Investigators will perform individual interviews with former PMD patients, and health and social care professionals to gain insights into current health care for PMD patients.

NCT ID: NCT04179526 Completed - Clinical trials for Major Depressive Disorder

Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems

REBTonAd
Start date: January 25, 2020
Phase: N/A
Study type: Interventional

To investigate the efficacy and mechanisms of change of an Internet-delivered transdiagnostic REBT intervention for adolescents with internalizing problems.

NCT ID: NCT04160806 Completed - Panic Disorder Clinical Trials

The Effect Of Transcranial Direct Current Stimulation In Panic Disorder

PDStim
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The aim of the present study is to investigate the effect of prefrontal transcranial Direct Current Stimulation (tDCS) on clinical severity, attentional bias and interoceptive accuracy in panic disorder (PD). The participants will be assigned to active and sham groups (1:1) and will receive 10 sessions of tDCS. The study will also examine if the effects may last for a month.

NCT ID: NCT04048824 Recruiting - Panic Disorder Clinical Trials

Optimizing Exposure Therapy for Anxiety Disorders

OptEx
Start date: August 14, 2015
Phase: N/A
Study type: Interventional

The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.